Strategic Portfolio Expansion
Three Seasons Wealth Significantly Increases Stakes in Four Major Stocks, Diversifying Portfolio
Anonymous
Key Points
1
Teradyne stake accounts for about 0.9% of Three Seasons Wealth's portfolio and ranks as the 29th-largest holding.
2
Exelixis stake makes up about 1.0% of Three Seasons Wealth's portfolio and is the 28th-largest position.
3
Albemarle stake accounts for about 1.0% of Three Seasons Wealth's portfolio and is the 26th-largest holding.
4
Dollar General: Three Seasons Wealth established a new stake of 4,139 shares valued at about $491,000; DG shares opened at $121.32, with a 52-week range of $95.11 to $158.23 and a market cap around $26.8B.
5
Teradyne's stock metrics on the reporting day included an opening price of $342.12, a market capitalization of about $53.56B, a price-earnings ratio of 63.36, a PEG ratio of 1.02, and a beta of 1.74.
Three Seasons Wealth LLC made a big push into several stocks during the first quarter, sharply increasing its stake in Teradyne by 77.6% to 8,226 shares, valued at about $2.44 million, according to Watchlist News. The firm also made moves in Exelixis, Albemarle, and Dollar General, signaling a broad effort to diversify and grow its mid- to large-cap holdings.
The buying spree placed Teradyne as the 29th-largest holding in Three Seasons Wealth's portfolio, making up roughly 0.9% of its total assets. The firm also picked up new stakes and boosted existing ones across multiple sectors during the same period, according to Ticker Report.
Teradyne Stake Nearly Doubles in One Quarter
Three Seasons Wealth added enough Teradyne shares to grow its position by 77.6% in just three months. The firm now holds 8,226 shares worth about $2.44 million. On the reporting day, Teradyne stock opened at $342.12. The company carries a market cap of roughly $53.56 billion, a price-earnings ratio of 63.36, and a beta of 1.74, meaning it moves more than the broader market.
A PEG ratio of 1.02 suggests the stock is fairly valued when you factor in growth expectations. A PEG ratio compares a stock's price to its expected earnings growth — a number near 1.0 is generally seen as balanced. Teradyne now ranks as the 29th-largest position in the portfolio, according to Ticker Report.
Exelixis Stake Jumps by More Than 345%
The biggest percentage move Three Seasons Wealth made was in Exelixis, a cancer drug maker. The firm grew that stake by 345.6%, bringing its total to 59,519 shares worth about $2.55 million. That makes Exelixis the 28th-largest holding, at roughly 1.0% of the portfolio, according to Watchlist News.
That kind of jump — more than quadrupling a position in a single quarter — stands out even among active institutional buyers. It points to a strong conviction bet on the biotech sector at a time when many investors have been cautious about drug stocks.
Albemarle Gets a 146% Boost as Lithium Bet Grows
Three Seasons Wealth also nearly tripled its position in Albemarle, a specialty chemicals company tied closely to lithium and battery materials. The firm bought 9,013 new shares, bringing its total to 15,178 shares worth about $2.73 million, according to Ticker Report. Albemarle now ranks as the 26th-largest holding, making up about 1.0% of the total portfolio.
Albemarle has faced a volatile stretch as lithium prices have fluctuated. Still, Three Seasons Wealth's 146.2% increase suggests the firm sees long-term value in the company's position as a key supplier to the electric vehicle industry.
Dollar General Gets a Brand-New Position Worth $491,000
Three Seasons Wealth also opened a fresh stake in Dollar General, buying 4,139 shares valued at about $491,000. Dollar General stock opened at $121.32 on the reporting day, with a 52-week range stretching from $95.11 to $158.23. The company's market cap sits at around $26.8 billion, according to Watchlist News.
The new position is smaller than the firm's other holdings but signals an interest in discount retail as a defensive play. Dollar General tends to hold up better during economic slowdowns, as shoppers trade down to lower-cost stores. The firm also opened a new position in Amkor Technology, buying 15,632 shares worth $704,000 during the same quarter, according to Ticker Report.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
26
Articles
10
Reach
36
Topics
A
AnonymousAuthor